The FDA Tobacco Control Act: What it Means for You

Myers, Matthew

Wednesday, August 15, 2012: 1:00 PM

3501 GH (Kansas City Convention Center)

Matthew Myers, JD , Campaign for Tobacco-Free Kids, Washington, DC

Diane Canova, JD , American Legacy Foundation, Washington, DC

Eric Lindblom, JD , FDA Center for Tobacco Products

Sanjay Koyani, MPH , US Food and Drug Administration, Center for Tobacco Products, Rockville

Learning Objectives

At the conclusion of this presentation attendees will be able to:

Describe the primary regulatory authorities granted to the FDA and states/localities through the TCA and list three major accomplishments under the TCA
Describe three examples of how TCA/CTP efforts can be supported by/incorporated into their programs
Describe the basic elements of the regulator process and provide three examples of how CTP varies from US tobacco control efforts to date

Cross Cutting Program Area(s): Tobacco Regulation and Tobacco Control Movement – Skills Building

Audience: All attendees

Key Points: This session is aimed to increase understanding of the new efforts in tobacco product regulation, knowledge, awareness, and support for which will be a critical skill for the evolving tobacco control movement.

Educational Experience: It will consist of 5 topics to include: a brief summary of the tobacco control act, a summary of CTP and what it means to be a regulatory agency, the role of partners/engaging for the FDA in terms of regulatory process; the role for partners with the FDA in terms of health communications; and a presentation on the state or local perspective in terms of the passage of TCA and tobacco product regulation as a new, complementary tool to other ongoing policy change and public education efforts.

Benefits: Attendees will be able describe the basic elements of the regulatory process; list three major accomplishments under the TCA and describe three examples of how TCA/CTP efforts can be supported by/incorporated into their programs